Results 191 to 200 of about 202,243 (244)

Sentinel Lymph Node Biopsy in Clinically Node‐Negative Merkel Cell Carcinoma: An Update of the Westmead Hospital Experience

ANZ Journal of Surgery, EarlyView.
ABSTRACT Background Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous neuroendocrine malignancy with a high risk of nodal metastasis. Sentinel lymph node biopsy (SLNB) is used to stage clinically node‐negative disease and to guide adjuvant therapy decisions.
Julie Ahn, Julie R. Howle, Michael J. Veness   +2 more
wiley   +1 more source

Anastomotic Failure Is Not Affected by Anastomotic Technique in Minimally Invasive Two‐Stage Oesophagectomy

ANZ Journal of Surgery, EarlyView.
ABSTRACT Background The choice of anastomotic technique in minimally invasive oesophagectomy (MIO) may influence postoperative morbidity and long‐term outcomes. The primary aim of our study is to determine whether circular (CS) or linear‐stapled (LS) anastomosis is associated with anastomotic complications following MIO.
L. Vu, C. Cabalag, L. Ng, B. Choo, A. Hardley, S. Kariyawasam   +5 more
wiley   +1 more source

Neuroendocrine tumour

, 2010
openaire   +1 more source

Other pancreatic neuroendocrine tumours with ectopic hormone production

La Rosa S, Hong SM, Mete O, Basturk O, Asa SL, Ezzat S, Brosens LAA   +6 more
core  

Surgery on neuroendocrine tumours

Best Practice & Research Clinical Endocrinology & Metabolism, 2007
Neuroendocrine tumours of the gastrointestinal tract and pancreas present a major challenge to physicians in their recognition and treatment requirements, and surgical treatment of these tumours has become increasingly important for symptom palliation and survival. For some carcinoid tumours the extent of surgery may depend on tumour size.
Per Hellman
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Tumour biology and histopathology of neuroendocrine tumours

Best Practice & Research Clinical Endocrinology & Metabolism, 2007
The tumours of the disseminated/diffuse neuroendocrine cell system are a group of neoplasms sharing uniformly appearing cells which differ from each other in their biology, prognosis and genetics. In the lung they are called carcinoid and small/large-cell neuroendocrine carcinomas.
Günter Klöppel
exaly   +3 more sources

Neuroendocrine tumours—challenges in the diagnosis and classification of pulmonary neuroendocrine tumours

Journal of Clinical Pathology, 2013
Pulmonary neuroendocrine (NE) proliferations are a diverse group of disorders which share distinct cytological, architectural and biosynthetic features. Tumours composed of NE cells are dispersed among different tumour categories in the WHO classification of tumours and as such do not conform to a singular group with regards to treatment and prognosis.
den Bakker, M.A., Thunnissen, F.B.J.M.
openaire   +4 more sources

Classification of neuroendocrine tumours.

, 2006
RINDI G, BORDI, Cesare
openaire   +3 more sources

Neuroendocrine tumours

, 2022
Mete O, Asa SL, de Krijger RR, Hicks MJ, Kimura N, La Rosa S, Tischler AS   +6 more
openaire   +2 more sources

The tumour microenvironment of pituitary neuroendocrine tumours

Frontiers in Neuroendocrinology, 2020
The tumour microenvironment (TME) includes a variety of non-neoplastic cells and non-cellular elements such as cytokines, growth factors and enzymes surrounding tumour cells. The TME emerged as a key modulator of tumour initiation, progression and invasion, with extensive data available in many cancers, but little is known in pituitary tumours. However,
Pedro Marques, Ashley B. Grossman, Márta Korbonits   +2 more
openaire   +2 more sources